
The round was led by DAG Ventures, with participation from Kleiner Perkins Caufield & Byers (KPCB), Delphi Ventures, Synergy Partners International and Johnson & Johnson Development Corporation.
In conjunction with the funding, industry leader John L. Miclot joined the company as chairman of the board.
The financing will fund commercialization of Breathe’s ultralight, mobile ventilation system, which has received FDA 510(k) clearance, as well as development of the company’s novel solutions for the sleep-disordered breathing market.
FinSMEs
18/05/2010